Network origin in Nathalie Trépo first degree
Entity | Entity type | Industry | |
---|---|---|---|
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France.
11
| Holding Company | Biotechnology | 11 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Nathalie Trépo via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
TXCELL | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
ADOCIA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Genclis SA
Genclis SA Miscellaneous Commercial ServicesCommercial Services Genclis SA operates as a holding company with interest in providing research services to the medical and biotechnology firms. The company was founded by Jean Cinqualbre in 2006 and is headquartered in Vandoeuvre-les-Nancy, France. | Miscellaneous Commercial Services | Chief Executive Officer | |
PricewaterhouseCoopers France SARL
PricewaterhouseCoopers France SARL Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers France provides accounting and business management consulting services. It offers expertise in auditing, financial strategy, legal advise, and investment. The company was founded on May 30, 1963 and is headquartered in Neuilly-sur-Seine, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Lazard Group LLC
Lazard Group LLC Investment ManagersFinance Lazard Group LLC provides financial advisory, asset management, and other financial services. The firm offers services related to mergers and acquisitions, strategic advisory, middle market advisory, capital markets and capital structure advisory, sovereign advisory, restructuring, and private fund advisory. The company was founded in 1840 and is headquartered in New York, NY. | Investment Managers | Corporate Officer/Principal | |
Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd. | Director/Board Member | ||
ELSALYS BIOTECH | Pharmaceuticals: Major | Chairman | |
The French Society of Financial Analysts | College/University | Corporate Officer/Principal | |
EURAZEO SE | Investment Managers | Corporate Officer/Principal | |
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. engages in theresearch and development, and manufacture of immunotherapies for the treatment of oncology and infectious diseases. Its business scope includes biopharmaceutical technology development, technology transfer, and related technical advisory services. The company was founded on July 26, 2010 and is headquartered in Tianjin, China. | Miscellaneous Commercial Services | Director/Board Member | |
Cottages Participations SAS | Miscellaneous | Chairman | |
SANGAMO THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
EG 427
EG 427 Miscellaneous Commercial ServicesCommercial Services EG 427 is a French biotechnology company that specializes in gene therapy. The location of the company is unknown. The company was founded by Alberto Epstein, François Giuliano, and Philippe O. Chambon, with Philippe O. Chambon serving as CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Platine Pharma Services SAS
Platine Pharma Services SAS Medical/Nursing ServicesHealth Services Based in Lyon within the Center of excellence in Infectious Diseases, Platine Pharma Services is an essential source of immune information for scientists and clinicians. From protocol support to regulatory reports, the company designs, performs and interprets complex molecular and cellular assays. Platine actively supports the development of in-vitro diagnostic, cosmetic and therapeutic product candidates, highlighting key markers and features in both normal and pathological conditions, and guiding decisions at each development stage. Using state-of-the-art technologies such as multi-parametric flow cytometry, Singulex, Luminex, Mesoscale Discovery, ELISpot or ELISA, Platine Pharma Services offers a fit-for-purpose approach to its customers and partners. | Medical/Nursing Services | Director/Board Member | |
Transgene, Inc. | Director/Board Member | ||
Biospace Lab SA
Biospace Lab SA Electronic Equipment/InstrumentsElectronic Technology Biospace Lab SA develops and produces imaging tools. Its products include optical imaging systems and digital autoradiography solutions. The company was founded by Georges Charpak in 1989 and is headquartered in Nesles la Vallée, France. | Electronic Equipment/Instruments | Director/Board Member | |
Université Paris Dauphine-PSL | College/University | Graduate Degree | |
University of Lyon | College/University | Undergraduate Degree | |
TRANSGENE | Biotechnology | Director of Finance/CFO | |
INNATE PHARMA | Pharmaceuticals: Major | Director of Finance/CFO | |
Argobio SAS
Argobio SAS Miscellaneous Commercial ServicesCommercial Services Argobio SAS is a start-up studio founded in 2021 and based in Paris, FR. The company was initiated by Kurma Partners, a leading healthcare venture capital firm based in France, and Bpifrance, the French national investment bank. The French company aims to nurture and launch at least five breakthrough biotech companies over the next five years by sourcing innovative early-stage projects from renowned European academic research institutions. The focus is on selected therapeutic areas, including rare diseases, neurological disorders, oncology, and immunology. Argobio will identify, select, and incubate these projects up to company creation and beyond, providing broad expertise in the discovery and development of novel drugs with a team of highly experienced biotech entrepreneurs. The internal team is led by Yves Ribeill, Neill Mackenzie, Poul Sørensen, and Rémi Soula. Thierry Laugel, Managing Partner at Partners, is the President of Argobio. Kurma and Bpifrance were joined by complementary strategic investors, Angelini Pharma, a private international pharmaceutical company, Evotec, a drug discovery alliance and development partnership company, and the Institut Pasteur, an internationally renowned center for biomedical research. | Miscellaneous Commercial Services | Chairman | |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Director/Board Member | |
Ribogenics, Inc.
Ribogenics, Inc. BiotechnologyHealth Technology Ribogenics, Inc. is a biotechnology company. The private company is based in Philadelphia, PA. The CEO of the company is Yves Joseph Ribeill. | Biotechnology | Director/Board Member | |
Kurma Partners SA
Kurma Partners SA Investment ManagersFinance Kurma Partners SA (KP) is an independent venture capital firm founded in 2009 by Thierry Laugel. The firm is headquartered in Paris, France. | Investment Managers | Director/Board Member | |
Emertee Gestion | Director/Board Member | ||
Demeter Ventures SA
Demeter Ventures SA Investment ManagersFinance 123 Investment Managers SA is a Private Equity/Venture Capital firm, a subsidiary of Capucines Capital Partners SAS founded in 2000. 123 Investment Managers SA is headquartered in Grenoble. | Investment Managers | Director/Board Member | |
Andera Partners SCA
Andera Partners SCA Investment ManagersFinance Andera Partners SCA (Andera Partners) is a private equity firm founded in 2001 by Pierre-Michel Passy. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor | |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Pharmaceuticals: Major | Chief Executive Officer | |
Vivet Therapeutics SAS
Vivet Therapeutics SAS BiotechnologyHealth Technology Vivet Therapeutics SAS develops novel gene therapy treatments for inherited metabolic diseases. The firm offers its services under the categorizers of Biopharma, Biotechnology and Health Care. The company was founded by Jean-Philippe Combal, Gloria Gonzalez-Aseguinolaza and Jens Kurth on July 26, 2016 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
Jeito Capital SASU
Jeito Capital SASU Investment ManagersFinance Jeito Capital SASU (Jeito Capital) is an Independent Venture Capital firm founded in 2018 by Rafaele Tordjman and headquartered in Paris, France. | Investment Managers | Private Equity Investor | |
Entact Bio, Inc.
Entact Bio, Inc. BiotechnologyHealth Technology Entact Bio, Inc. is a company that focuses on creating new medicines by enhancing protein function. The company is based in Watertown, MA. The company is a team of scientists, entrepreneurs, drug creators, and problem solvers who work together to bring new medicines to patients who currently have few options. The CEO of the company is Victoria M. Richon. The founder of the company grew up in chaos and instability in an undisclosed capital city and has always been passionate and motivated to help enhance and provide medical solutions. | Biotechnology | Director/Board Member | |
University of Oxford | College/University | Graduate Degree | |
University of Bristol | College/University | Undergraduate Degree | |
Locki Therapeutics Ltd.
Locki Therapeutics Ltd. BiotechnologyHealth Technology Locki Therapeutics Ltd. is a British preclinical stage biotechnology company founded in 2019. The company is based in London, UK. Locki Therapeutics is developing a new class of drugs that enhance the function of beneficial proteins. The company has designed its proprietary encompass™ platform to create enhancement-targeting chimeric (entac™) medicines. These entacs harness the ability of dubs to regulate proteins, expanding the universe of treatable diseases. | Biotechnology | Director/Board Member | |
4BIO Ventures Management Ltd.
4BIO Ventures Management Ltd. Investment ManagersFinance 4BIO Ventures Management Ltd (4bio Capital Partners) is an independent venture capital firm founded in 2014 by Andrey Kozlov. The firm headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
CytoKi Pharma ApS
CytoKi Pharma ApS Miscellaneous Commercial ServicesCommercial Services CytoKi Pharma ApS engages in the research and experimental development within biotechnology. It develops therapeutics for serious tissue and organ injuries. The company was founded by Rasmus Jørgensen on June 12, 2019 and is headquartered in Vaerlose, Denmark. | Miscellaneous Commercial Services | Director/Board Member | |
Aelix Therapeutics SL
Aelix Therapeutics SL BiotechnologyHealth Technology Aelix Therapeutics SL researches and develops therapies for HIV. It develops therapeutic vaccines and immunotherapies to treat HIV infection. The firm is a spin-off of HIVACAT, the Catalan project for the development of effective vaccines against HIV. The company was founded by Christian Brander, Bonaventura Clotet, Josep Maria Gatell and Jordi Naval is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
Aelix, Inc.
Aelix, Inc. Internet Software/ServicesTechnology Services Part of Billing Services Group Ltd., Aelix, Inc. provides intelligent communications solutions to enterprises, notably in the travel and hospitality, financial services, and electronic commerce sectors. The company is based in Los Angeles, CA. Aelix was acquired by Avery Communications, Inc. from ComF5 International, Inc. on December 04, 2001 for $4.10 million. | Internet Software/Services | Director/Board Member | |
GALECTO, INC. | Pharmaceuticals: Major | Director/Board Member | |
Xeltis AG
Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Medical Specialties | Director/Board Member | |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member |
Statistics
International
France | 29 |
United States | 11 |
United Kingdom | 5 |
China | 3 |
Denmark | 3 |
Sectoral
Health Technology | 20 |
Commercial Services | 11 |
Finance | 8 |
Consumer Services | 7 |
Miscellaneous | 2 |
Operational
Director/Board Member | 74 |
Corporate Officer/Principal | 25 |
Chief Executive Officer | 17 |
President | 16 |
Chairman | 15 |
Most connected contacts
Insiders | |
---|---|
Joseph Papa | 28 |
Stéphane Boissel | 24 |
Laurent Arthaud | 21 |
Jeanne Cunicelli | 19 |
Karen Wagner | 17 |
Benjamin Yerxa | 15 |
Mehdi Gasmi | 8 |
Geoffroy de Ribains | 7 |
Owen Smith | 6 |
Sabine Dandiguian | 3 |
Paul Sieving | 1 |
- Stock Market
- Insiders
- Nathalie Trépo
- Company connections